FDA OKs Cooling Cap to Reduce Hair Loss from Chemotherapy
By Stacy Simon The US Food and Drug Administration (FDA) has cleared for marketing a cooling cap to reduce hair loss in women being treated with chemotherapy for breast cancer. Hair loss is a common side effect of certain types of chemotherapy – including the types often used to treat breast cancer. Although hair typically grows back after treatment ends, it can take a long time. Reducing this side effect is considered important to overall treatment by improving quality of life for many women. The first device cleared by the FDA is the DigniCap Cooling System, manufactured by the Swedish company Dignitana, Inc. It us...
Source: American Cancer Society :: News and Features - December 9, 2015 Category: Cancer & Oncology Tags: Breast Cancer Coping with Cancer Source Type: news

ACS Releases Long-term Care Guideline for Breast Cancer Survivors
By Stacy Simon The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer survivors and their primary care providers better manage their long-term care. The guideline was published December 7, 2015 in CA: A Cancer Journal for Clinicians, a journal of the American Cancer Society. It provides detailed recommendations for how and when to test for new or returning cancers, managing side effects, making healthy lifestyle changes, and coordinating care among primary care providers and specialists. The guideline is the third in a se...
Source: American Cancer Society :: News and Features - December 7, 2015 Category: Cancer & Oncology Tags: Breast Cancer Coping with Cancer Source Type: news

Nurture Your Emotional Health
By Stacy SimonThe holiday season is a joyful time for many people, but for some it can lead to stress or trigger depression or other negative feelings. It’s important to take care of your physical health by eating right and exercising, but taking care of your emotional health and having a sense of happiness and well-being is important, too.The US Centers for Disease Control and Prevention (CDC) defines well-being as judging life positively and feeling good. According to the CDC, higher levels of well-being are linked to:A lower risk of disease, illness, and injury – and speedier recoveryA better-functioning imm...
Source: American Cancer Society :: News and Features - December 7, 2015 Category: Cancer & Oncology Tags: Coping with Cancer Source Type: news

New Brain Tumor Insight Could Help Several Cancers
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - December 4, 2015 Category: Cancer & Oncology Source Type: news

Six Plan-ahead Tips to Party Smarter
By Stacy Simon Sticking to your healthy eating goals can be a lot harder this time of year. But with a little planning, you can enjoy every minute of this season’s parties without going overboard on fat, calories, or sweets. Follow these 6 tips to enjoy all the festivities December has to offer, without having to pay for it later. Don't go hungry. Snack on healthy, filling foods before you leave the house. You'll be less tempted by high-calorie options if your stomach isn't growling. Good pre-party bets include a handful of nuts, cheese and crackers, or half a turkey sandwich. Get water first. Once you arriv...
Source: American Cancer Society :: News and Features - December 4, 2015 Category: Cancer & Oncology Tags: Diet/Exercise/Weight Source Type: news

Help Others, Help Yourself
By Stacy Simon Volunteering is all about helping others. But as many studies show, when you volunteer, one of the people who benefits most is you. Volunteering also has health benefits. A study by the Corporation for National and Community Service, a federal agency, linked volunteering to longer life, lower rates of depression, and less risk of heart disease. In other words, volunteering could actually make you happier and healthier. The research suggests that volunteering is particularly helpful for older adults and those who volunteer at least 2 hours a week: A study of adults age 65 and older found that the positiv...
Source: American Cancer Society :: News and Features - December 3, 2015 Category: Cancer & Oncology Tags: ACS Programs and Services Source Type: news

Prostate Cancer Screening and Detection Decline
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - December 2, 2015 Category: Cancer & Oncology Source Type: news

Cervical Cancer Detection on the Rise in Young Women
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - November 25, 2015 Category: Cancer & Oncology Source Type: news

FDA Approves Ninlaro (Ixazomib) for Multiple Myeloma
By Stacy SimonThe US Food and Drug Administration (FDA) has approved the third drug this year for treating multiple myeloma, a type of cancer that starts in plasma cells. Ninlaro (ixazomib) is a targeted therapy drug approved to be given in combination with two other drugs – lenalidomide and dexamethasone. This combination is the first all-oral regimen for treating multiple myeloma. It’s intended for people who have received at least one previous treatment.The FDA based its approval on a clinical trial of 722 people with multiple myeloma that didn’t get better with treatment, or came back after treatment....
Source: American Cancer Society :: News and Features - November 20, 2015 Category: Cancer & Oncology Tags: Multiple Myeloma Source Type: news

5 Questions with HPV Researcher Rebecca Perkins, MD
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - November 20, 2015 Category: Cancer & Oncology Source Type: news

FDA Approves Darzalex (Daratumumab) for Multiple Myeloma
By Stacy SimonThe US Food and Drug Administration (FDA) has approved the first monoclonal antibody to treat people with multiple myeloma, a type of cancer that starts in plasma cells. A monoclonal antibody is a type of immunotherapy drug that works by helping the body’s own immune system find and destroy cancer cells. Darzalex (daratumumab) is for people with multiple myeloma who have tried at least 3 other drug treatments.The FDA based its approval on 2 studies. In the first study, 106 people were given Darzalex and 29% saw a reduction in the amount of cancer in their bodies, which lasted for an average 7.4 months. ...
Source: American Cancer Society :: News and Features - November 17, 2015 Category: Cancer & Oncology Tags: Multiple Myeloma Source Type: news

New ACS Children’s Book Tackles Emotional Effects of Cancer
By Stacy Simon In My Cancer Days, a little girl with cancer experiences a range of emotions depending on how she feels on different days. On a purple day, for example, she feels scared; on a yellow day, she feels happy. “I wrote My Cancer Days for the smallest warriors,” said author Courtney Filigenzi. “Children can have a hard time identifying or describing their feelings. I wanted to help kids find the words they need to express how they’re feeling inside.” RESOURCES: Video: My Cancer DaysPurchase My Cancer DaysMore American Cancer Society books for childrenWhen Your Child Has Cancer ...
Source: American Cancer Society :: News and Features - November 17, 2015 Category: Cancer & Oncology Tags: Childhood Cancer Coping with Cancer Source Type: news

It’s Never Too Late to Quit Smoking
By Stacy SimonAbout half of all Americans who smoke and don’t quit will die because of smoking. That’s one of the reasons it’s so important to quit, and the sooner the better. But quitting is rewarding no matter how old you are or whether you have health problems. Studies show that even after age 80, people can live healthier if they give up cigarettes.And the benefits are almost immediate. Ex-smokers have fewer illnesses such as colds and the flu, lower rates of bronchitis and pneumonia, and feel healthier than people who still smoke. Just 20 minutes after quitting, your heart and blood pressure drop. I...
Source: American Cancer Society :: News and Features - November 16, 2015 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news

FDA Approves Tagrisso (Osimertinib) for Non-Small Cell Lung Cancer
By Stacy SimonThe US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) to treat people with a type of advanced non-small cell lung cancer. It’s for lung cancers with a specific epidermal growth factor receptor (EGFR) mutation called T790M that have gotten worse after treatment with other EGFR-blocking drugs.Some lung cancer cells to have too much of the EGFR protein, which leads them to grow faster. EGFR-blocking drugs work by interrupting the signal from the protein that tells cells to grow. But these drugs tend to stop working over time, often as the result of new mutations in the EGFR gene, su...
Source: American Cancer Society :: News and Features - November 13, 2015 Category: Cancer & Oncology Tags: Lung Cancer - Non-Small Cell Source Type: news

Standing May Help Ward Off Obesity
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - November 13, 2015 Category: Cancer & Oncology Source Type: news